Treatment of Lupus Nephritis in the 21st Century
Glomerulonephritis remains one of the most severe complications of systemic lupus erythematosus and is associated with significant morbidity and mortality.
Is AIDS a Virus or Bacteria?
AIDS is neither a virus nor bacterium; it is a syndrome (a series of conditions) caused by a virus called HIV (human immunodeficiency virus). This viral pathogen, which targets the cells of the immune system, often leads to the development of AIDS in HIV-positive people.
News Briefs
Review the latest in HIV research, including gene therapy for HIV-infected children, and the search for participants for a Kaposi's sarcoma drug trial.
Parkinson's Early Symptoms
Parkinson's is a disease of the nervous system that worsens over time. Parkinson's begins with barely noticeable symptoms such as depression, tremors and stiffness of the muscles in the limbs or face. As the disease progresses, symptoms interfere with daily life and render a person incapable of taki
Candidate HIV/AIDS Vaccines
In 2003 the results of the first two efficacy trials of candidate HIV-1 vaccines will be available.
HIV Risk Among Circumcised and Uncircumcised Men With HPV
Are men with penile HPV infection at increased risk for HIV acquisition? How does circumcision factor in?
Darunavir and Trimethoprim-Sulfamethoxazole Cross-Reactivity
Can DRV be administered in HIV patients allergic to TMP-SMX? This study examines the cross-reactivity between both drugs.
The New York Case Revisited
Did the details of a single case with highly resistant HIV and rapid disease progression warrant the controversial alarm sounded by the NYC Department of Health?
Effectiveness of HIV Treatment as Prevention Among MSM
Is TasP with high retention in HIV care and universal treatment coverage sufficient to reduce HIV transmission?
Primary HIV Infection Symptoms
HIV is an acronym for the human immunodeficiency virus, an incurable illness that over time destroys the body's immune system. It is spread through unprotected sexual or blood contact, and becomes visible in a toxicology screening between three and six months after infection. Individuals who have b
Immunologic and Clinical Responses to Highly Active
Clinicians are seeing an increasing number of older HIV-seropositive patients, but few data exist with specific regard to treatment and outcomes in older adults. In this study, patients > 50 years of
Approaches to Immunosuppression in Behcet's Disease
Gain new insights into Becet's Disease immunopathology and a new area of targeted therapy.
A V106M Mutation in HIV-1 Clade C Viruses Exposed ...
Highly active antiretroviral therapy with the three classes of antiretroviral drugs, namely nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTI and NNRTI) and protease inhibitors (PI) has helped to stabilize disease progression of predominantly subtype B infections in Western ...
The Challenges of Treatment as Prevention Among MSM
Can the treatment as prevention model reduce HIV transmission in men who have sex with men?
New York Course 2007: ART Controversies-- Expert Interview with Dr. Hirsch
HIV Management 2007: Dr. Hirsch speaks with Medscape about guidelines for initiating antiretroviral therapy, how they have changed over time, and how and why they may change in the future.
How Do You Get HIV?
Sexual TransmissionYou can get HIV from anal, oral or vaginal sex with an infected person. Incidences of transmission vary greatly by practice, however; you are much more likely to catch something else from your partner than HIV. In fact, according to an article in the British Medical...
HIV Ethics Information
The arrival of HIV/AIDS has created a new discussion of ethical responsibility in the medical field. Ethics involve determining what is right and wrong through moral reasoning. The medical community has seen increasing debate over the ethical considerations for those suffering from HIV and AIDS.
HIV Risk in Young People
In the U.S., over 12,000 people under the age of 25 are infected with HIV each year. Find out why, and ways to help reduce HIV risk.
Might Treatment-On-Infection Allow For Treatment Interruption?
Researcher with the French PRIMO cohort study have questioned whether early treatment might slow, if not entirely prevent, HIV disease progression.